These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35453934)

  • 21. Decreased serum levels of angiotensin converting enzyme (ACE)2 and enhanced cytokine levels with severity of COVID-19: normalisation upon disease recovery.
    Mortaz E; Jamaati H; Roofchayee ND; Sheikhzade H; Mirenayat M; Sadeghi M; Lookzadeh S; Dezfuli NK; Folkerts G; Mumby S; Garssen J; Adcock IM
    Heliyon; 2022 Feb; 8(2):e08957. PubMed ID: 35187271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.
    Osman IO; Melenotte C; Brouqui P; Million M; Lagier JC; Parola P; Stein A; La Scola B; Meddeb L; Mege JL; Raoult D; Devaux CA
    Front Immunol; 2021; 12():625732. PubMed ID: 34194422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic.
    Cauwenberghs N; Prunicki M; Sabovčik F; Perelman D; Contrepois K; Li X; Snyder MP; Nadeau KC; Kuznetsova T; Haddad F; Gardner CD
    Am J Clin Nutr; 2021 Nov; 114(5):1655-1665. PubMed ID: 34375388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The collectrin-like part of the SARS-CoV-1 and -2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17.
    Niehues RV; Wozniak J; Wiersch F; Lilienthal E; Tacken N; Schumertl T; Garbers C; Ludwig A; Düsterhöft S
    FASEB J; 2022 Mar; 36(3):e22234. PubMed ID: 35199397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.
    Okoloko O; Vanderwall ER; Rich LM; White MP; Reeves SR; Harrington WE; Barrow KA; Debley JS
    Front Pharmacol; 2021; 12():765951. PubMed ID: 34867390
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin-Converting Enzyme 2 Correlates With Renin and Body Mass Index.
    Jehpsson L; Sun J; Nilsson PM; Edsfeldt A; Swärd P
    Front Physiol; 2020; 11():622179. PubMed ID: 33519526
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of angiotensin II receptor blocker usage on viral load, antibody dynamics, and transcriptional characteristics among COVID-19 patients with hypertension.
    Feng B; Zhang D; Wang Q; Yu F; Zou Q; Xie G; Wang R; Yang X; Chen W; Lou B; Zheng S; Chen Y
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):330-340. PubMed ID: 33835767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble ACE2 as a Risk or Prognostic Factor in COVID-19 Patients: A Cross-sectional Study.
    Mohammadi P; Varpaei HA; Seifi A; Zahak Miandoab S; Beiranvand S; Mobaraki S; Mohammadi M; Abdollahi A
    Med J Islam Repub Iran; 2022; 36():135. PubMed ID: 36479537
    [No Abstract]   [Full Text] [Related]  

  • 30. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.
    Mir MM; Mir R; Alghamdi MAA; Alsayed BA; Wani JI; Alharthi MH; Al-Shahrani AM
    J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
    Fließer E; Birnhuber A; Marsh LM; Gschwandtner E; Klepetko W; Olschewski H; Kwapiszewska G
    J Pathol Clin Res; 2021 Sep; 7(5):446-458. PubMed ID: 33978304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.
    Sheikhi A; Hojjat-Farsangi M
    Hum Vaccin Immunother; 2021 Jan; 17(1):92-97. PubMed ID: 32663051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of soluble angiotensin-converting enzyme 2 in saliva samples and its association with nicotine.
    Bru S; González-Marrón A; Lidón-Moyano C; Carballar R; Martínez-Láinez JM; Pérez-Martín H; Fu M; Pérez-Ortuño R; Ballbè M; Pascual JA; Fernández E; Clotet J; Martínez-Sánchez JM
    Environ Res; 2023 Jan; 216(Pt 1):114443. PubMed ID: 36195157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failure.
    Shao Z; Shrestha K; Borowski AG; Kennedy DJ; Epelman S; Thomas JD; Tang WH
    J Card Fail; 2013 Sep; 19(9):605-10. PubMed ID: 24054336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dynamic nature of the coronavirus receptor, angiotensin-converting enzyme 2 (ACE2) in differentiating airway epithelia.
    Manna VJ; Choi H; Rotoli SM; Caradonna SJ
    BBA Adv; 2022; 2():100044. PubMed ID: 35187520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.
    Letarov AV; Babenko VV; Kulikov EE
    Biochemistry (Mosc); 2021 Mar; 86(3):257-261. PubMed ID: 33838638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
    Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.